跳转到主要内容
搜索
会议

ISSX 27th North American Meeting

Conference: ISSX 27th North American Meeting

日期： 2026 年 10 月 11 - 14 日

地点： San Francisco, CA

At the ISSX 27th North American Meeting, themed “Back to the Future: DMPK Foundations and New Concepts,” Certara will showcase how biosimulation and strategic expertise can help drug developers make more confident, model-informed decisions from discovery through clinical development.

Join us at booth #503 or at one of our presentations listed below to connect with our experts and explore solutions for assessing drug-drug interactions, predicting clinical outcomes, and optimizing development strategies:

Presentations

Monday, October 12th | 10:00am - 12:00pm
Symposium 2: Latest advances in assessment of drug-drug interactions
  • Presentation title: PBPK model credibility assessment
  • 讲师： Karen Rowland Yeo, PhD, SVP, Client and Regulatory Strategy, Certara

海报

Tuesday, October 13th, 12:00 - 12:45pm
Recent Trends in Pharmacokinetic Drug-Drug Interaction Research: A Review of Clinical Data Published in the Literature in 2025

Presenting author: Sophie Argon, PharmD, Senior Scientist, Certara

Poster: P63​

Tuesday, October 13th, 12:00 - 12:45pm
In Vitro Inhibition of Cytochrome P450 by Glucuronide Metabolites: A Review of the Literature and Recent New Drug Applications

Presenting author: Eva Gil Berglund, PhD, VP, Clinical Pharmacology and Regulatory Strategy, Certara

Poster: P77​

Tuesday, October 13th, 12:45 - 1:30pm
Pharmacokinetic-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2025: A Review of Clinical Data Available in New Drug Application Reviews

Presenting author: Jingjing Yu, MD, PhD, Director, Drug Interaction Solutions, Certara

Poster: P66​

Wednesday, October 14th, 12:45 - 1:30pm
4-Pyridoxic Acid as an Endogenous Biomarker of Renal OAT3 Activity in Pregnancy: Separating Vitamin-B6 Supplementation from Renal Physiology Using NHANES Data and PBPK Modeling

Presenting author: Oliver Hatley, PhD, Senior Principal Scientist, Certara

Poster: P172​

Demos

Meet Us at ISSX 27th North American Meeting (Booth #503)

Request a meeting with our team ahead of the conference.

Whether you’re interested in a software demo or scientific consultation, let us know what you’d like to discuss, and we’ll connect you with the right expert.


Additional Resources

精选推荐

Model-Informed Strategies for ADC Development
Model-Informed Strategies for ADC DevelopmentWhite Paper

Model-Informed Strategies for ADC Development

When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing
When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based DosingPublication

When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing

Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers
Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy VolunteersPublication

Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers

事实资料表

From first-in-human trials to global regulatory approvals and post-launch, Certara solutions can help you move your science forward faster, with confidence.

立即下载

沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software